ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 19 filers reported holding ADMA BIOLOGICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $74,000 | -62.1% | 20,000 | -50.0% | 0.00% | -62.5% |
| Q1 2017 | $195,000 | -61.9% | 40,000 | -60.0% | 0.01% | -68.0% |
| Q4 2016 | $512,000 | -39.6% | 100,000 | -14.5% | 0.02% | -51.9% |
| Q3 2016 | $847,000 | +0.1% | 117,000 | -17.7% | 0.05% | -20.0% |
| Q2 2016 | $846,000 | -27.9% | 142,155 | -2.0% | 0.06% | +27.5% |
| Q1 2016 | $1,173,000 | -9.1% | 145,000 | -9.4% | 0.05% | -42.7% |
| Q4 2015 | $1,291,000 | +0.3% | 160,000 | +3.9% | 0.09% | +56.1% |
| Q3 2015 | $1,287,000 | +54.5% | 154,000 | +71.1% | 0.06% | +72.7% |
| Q2 2015 | $833,000 | +60.2% | 90,000 | +69.5% | 0.03% | +43.5% |
| Q1 2015 | $520,000 | – | 53,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,433,304 | $4,415,000 | 5.01% |
| Aisling Capital LLC | 3,608,171 | $11,113,000 | 1.83% |
| Iguana Healthcare Management, LLC | 1,130,000 | $3,480,000 | 0.96% |
| Consonance Capital Management LP | 1,273,933 | $3,924,000 | 0.43% |
| Perceptive Advisors | 1,442,204 | $4,442,000 | 0.08% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 39,000 | $120,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 11,673 | $36,000 | 0.00% |
| Renaissance Technologies | 20,300 | $63,000 | 0.00% |
| ROYAL BANK OF CANADA | 2 | $0 | 0.00% |
| VANGUARD GROUP INC | 311,514 | $960,000 | 0.00% |